Oxygène Médicinal Gazeux Vivisol (Oxygen)

Oxygen, the active ingredient in Oxygène Médicinal Gazeux Vivisol, is a medical gas presented as a gaseous form for inhalation use. It supports patients with respiratory insufficiency and is used in emergency and peri‑operative settings. GNH USA supplies Oxygène Médicinal Gazeux Vivisol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

GNH USA supplies Oxygène Médicinal Gazeux Vivisol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Oxygène Médicinal Gazeux Vivisol is a medical gas used in respiratory support and related clinical pathways. - Acute hypoxemia: provides supplemental oxygen to raise arterial oxygen levels. - Peri‑operative care: maintains adequate oxygenation during anesthesia and surgery. - Emergency medicine: delivers high‑flow oxygen for trauma, cardiac arrest and other urgent situations. - Chronic respiratory disease management: assists patients with COPD or interstitial lung disease during exacerbations. - Neonatal care: supports preterm infants with under‑developed lungs. - Hyperbaric therapy adjunct: used as the carrier gas in hyperbaric oxygen chambers.

Oxygen therapy is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Nasal dryness or irritation: discomfort in the nasal passages from high‑flow delivery. - Headache: mild to moderate headache related to changes in carbon dioxide levels. - Cough: irritation of the airway causing a cough reflex. - Fatigue: transient tiredness after prolonged exposure. - Burning sensation: feeling of warmth at the cannula or mask site.

Serious or Rare Side Effects: - Pulmonary oxygen toxicity: lung injury from prolonged high concentrations. - Fire hazard: increased risk of combustion when oxygen is present near flammable sources. - Hypercapnia: elevated carbon dioxide levels in patients with hypoventilation. - Visual disturbances: temporary changes in vision due to retinal oxygen overload. - Barotrauma: ear or sinus injury from rapid pressure changes during high‑flow administration.

When using Oxygène Médicinal Gazeux Vivisol, follow established clinical guidelines and monitor patients closely. - Assess patient need: confirm indication and target oxygen saturation before initiating therapy. - Adjust flow rate: titrate to the lowest flow that maintains adequate oxygenation. - Monitor for toxicity: watch for signs of pulmonary oxygen toxicity during prolonged high‑concentration use. - Avoid fire sources: keep away from open flames, sparks and combustible materials. - Special populations: use caution in patients with chronic CO2 retention, such as severe COPD. - Store at ambient temperature: keep cylinders in a well‑ventilated, dry area away from direct sunlight and heat sources.

Oxygen can influence the efficacy and safety of several concurrent therapies. Proper assessment and monitoring are essential.

Major Interactions (Avoid): - Flammable anesthetics: increased fire risk when oxygen is combined with volatile agents. - Nitric oxide therapy: high oxygen concentrations can reduce the vasodilatory effect of inhaled nitric oxide.

Moderate Interactions (Monitor Closely): - Sedatives and opioids: enhanced respiratory depression risk; monitor ventilation. - Chemotherapy agents (e.g., bleomycin): oxygen may exacerbate pulmonary toxicity. - Antioxidant supplements: theoretical reduction in therapeutic benefit of hyperbaric oxygen. - Inhaled bronchodilators: may require dose adjustment due to improved oxygenation. - High‑flow nasal cannula systems: ensure compatibility of equipment and flow settings.